Company Filing History:
Years Active: 2014-2022
Title: The Innovative Contributions of Dingjiang Liu
Introduction
Dingjiang Liu is a prominent inventor based in Oak Park, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various diseases. With a total of six patents to his name, Liu's work has had a considerable impact on medical science.
Latest Patents
Among his latest patents is a method of treating diseases using an IL-17 receptor antibody formulation. This patent relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens aimed at effectively treating diseases. Another notable patent is also focused on the IL-17 receptor antibody formulation, further emphasizing the importance of AM-14 in therapeutic applications.
Career Highlights
Dingjiang Liu has worked with notable companies in the pharmaceutical industry, including Kirin-Amgen, Inc. and Amgen K.A., Inc. His experience in these organizations has allowed him to develop innovative solutions that address critical health challenges.
Collaborations
Throughout his career, Liu has collaborated with talented individuals such as Holly Zhuohong Huang and David Andrew Martin. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Dingjiang Liu's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in medical science. His work continues to pave the way for new treatments and advancements in healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.